These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24491490)

  • 41. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.
    Tzartos SJ; Cung MT; Demange P; Loutrari H; Mamalaki A; Marraud M; Papadouli I; Sakarellos C; Tsikaris V
    Mol Neurobiol; 1991; 5(1):1-29. PubMed ID: 1725702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myasthenogenicity in the main immunogenic region of acetylcholine receptor as modified by conformational design: an approach to antigenic synthetic peptides.
    Takamori M; Hamada T; Okumura S
    J Neurol Sci; 1992 Jun; 109(2):182-7. PubMed ID: 1634900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scanning a DRB3*0101 (DR52a)-restricted epitope cross-presented by DR3: overlapping natural and artificial determinants in the human acetylcholine receptor.
    Nagvekar N; Corlett L; Jacobson LW; Matsuo H; Chalkley R; Driscoll PC; Deshpande S; Spack EG; Willcox N
    J Immunol; 1999 Apr; 162(7):4079-87. PubMed ID: 10201931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of inter-animal cross-reaction of anti-acetylcholine receptor antibodies at the receptor-binding site as demonstrated by heterologous anti-idiotype antisera: implications for immunotherapy of myasthenia gravis.
    Barkas T; Simpson JA
    Clin Exp Immunol; 1982 Jan; 47(1):119-26. PubMed ID: 7094417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of anti-acetylcholine receptor (AChR) antibodies from mice differing in susceptibility for experimental autoimmune myasthenia gravis (EAMG).
    Graus YM; van Breda Vriesman PJ; de Baets MH
    Clin Exp Immunol; 1993 Jun; 92(3):506-13. PubMed ID: 8513583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of epitopes within a highly immunogenic region of acetylcholine receptor by a phage epitope library.
    Barchan D; Balass M; Souroujon MC; Katchalski-Katzir E; Fuchs S
    J Immunol; 1995 Nov; 155(9):4264-9. PubMed ID: 7594584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure of the acetylcholine receptor and specificities of antibodies to it in myasthenia gravis.
    Lindstrom JM
    Ciba Found Symp; 1982; (90):178-96. PubMed ID: 6923807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor alpha subunit.
    Hohlfeld R; Toyka KV; Tzartos SJ; Carson W; Conti-Tronconi BM
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5379-83. PubMed ID: 2955417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular modeling of the complex between Torpedo acetylcholine receptor and anti-MIR Fab198.
    Konstantakaki M; Tzartos SJ; Poulas K; Eliopoulos E
    Biochem Biophys Res Commun; 2007 May; 356(3):569-75. PubMed ID: 17376405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Construction and characterization of a humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor.
    Papanastasiou D; Mamalaki A; Eliopoulos E; Poulas K; Liolitsas C; Tzartos SJ
    J Neuroimmunol; 1999 Feb; 94(1-2):182-95. PubMed ID: 10376952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myasthenogenic significance of synthetic alpha-subunit peptide 183-200 of Torpedo californica and human acetylcholine receptor.
    Takamori M; Okumura S; Nagata M; Yoshikawa H
    J Neurol Sci; 1988 Jun; 85(2):121-9. PubMed ID: 3260271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Canine and human myasthenia gravis autoantibodies recognize similar regions on the acetylcholine receptor.
    Shelton GD; Cardinet GH; Lindstrom JM
    Neurology; 1988 Sep; 38(9):1417-23. PubMed ID: 3412590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection and characterization of blocking-type anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis.
    Hara H; Hayashi K; Ohta K; Itoh N; Nishitani H; Ohta M
    Clin Chem; 1993 Oct; 39(10):2053-7. PubMed ID: 8403390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.
    Atassi MZ; Ruan KH; Jinnai K; Oshima M; Ashizawa T
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5852-6. PubMed ID: 1378618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits.
    Tzartos SJ; Lindstrom JM
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):755-9. PubMed ID: 6153804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG.
    Oshima M; Deitiker P; Ashizawa T; Atassi MZ
    Autoimmunity; 2002 May; 35(3):183-90. PubMed ID: 12389643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amino acid residues within the sequence region alpha 55-74 of Torpedo nicotinic acetylcholine receptor interacting with antibodies to the main immunogenic region and with snake alpha-neurotoxins.
    Wahlsten JL; Lindstrom JM; Conti-Tronconi BM
    J Recept Res; 1993; 13(6):989-1008. PubMed ID: 8510074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of monoclonal antibodies to denatured Torpedo and to native calf acetylcholine receptors: species, subunit and region specificity.
    Tzartos S; Langeberg L; Hochschwender S; Swanson LW; Lindstrom J
    J Neuroimmunol; 1986 Jan; 10(3):235-53. PubMed ID: 3484485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains.
    Lindstrom J; Luo J; Kuryatov A
    Ann N Y Acad Sci; 2008; 1132():29-41. PubMed ID: 18567851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoclonal antibodies against synthetic sequences of the nicotinic receptor cross-react fully with the native receptor and reveal the transmembrane disposition of their epitopes.
    Lei S; Raftery MA; Conti-Tronconi BM
    Biochemistry; 1993 Jan; 32(1):91-100. PubMed ID: 7678197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.